Search alternatives:
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » greater decrease (Expand Search)
Showing 521 - 540 results of 10,193 for search 'significant ((level decrease) OR (((teer decrease) OR (mean decrease))))', query time: 0.40s Refine Results
  1. 521
    Prevalence of osteoporosis classified by sex, and urinary cadmium level compare between 2019 and 2022.

    Prevalence of osteoporosis classified by sex, and urinary cadmium level compare between 2019 and 2022. by Aroon La-up (14095691)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 522
    Expression level (2<sup>-ΔCq</sup>) of microRNA in the cerebellum of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats.

    Expression level (2<sup>-ΔCq</sup>) of microRNA in the cerebellum of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

    Published 2025
    Save to List
    Saved in:
  3. 523
    Expression level (2<sup>-ΔCq</sup>) of microRNA in the sperm of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats.

    Expression level (2<sup>-ΔCq</sup>) of microRNA in the sperm of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

    Published 2025
    Save to List
    Saved in:
  4. 524
    Expression level (2<sup>-ΔCq</sup>) of microRNA in the hypothalamus of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats.

    Expression level (2<sup>-ΔCq</sup>) of microRNA in the hypothalamus of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

    Published 2025
    Save to List
    Saved in:
  5. 525
    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 526
    Relative expression levels in TNF-α, IL-6, and p53 in co-culture and CM treatment of hypoxic and normoxic PANC-1 cells with CD8+ T-cells.

    Relative expression levels in TNF-α, IL-6, and p53 in co-culture and CM treatment of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 527
    Maximum likelihood estimates of trans-log mean stochastic function.

    Maximum likelihood estimates of trans-log mean stochastic function. by James Anaba Akolgo (14129379)

    Published 2025
    Save to List
    Saved in:
  8. 528
    Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa.

    Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa. by Beatrice T. Nganso (4114768)

    Published 2025
    Save to List
    Saved in:
  9. 529
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 530
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 531
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 532
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 533
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 534
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 535
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 536
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 537
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 538
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 539
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 540
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: